Yang and colleagues suggested that after the MIPI and MIPI-c score, TP53 and WHSC1 mutations were the most significant prognostic factors in MCL, and all patients benefited from WHSC1 and TP53 mutations at diagnosis [91]. This evidence concerns the gene TP53 and mantle cell lymphoma.